Latest Stock Split Details
Key information about Zhejiang Starry Pharmaceutical Co.,Ltd.'s most recent stock split
Split Date: 2022-06-17
Split Ratio: 7:5
Price Before Split: $42.69
Price After Split: $30.49
Developer API
Get 603520.SS split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/603520.SS
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.40 times more shares (a 7:5 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Zhejiang Starry Pharmaceutical Co.,Ltd.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-06-17 | 7:5 | No | $42.69 | $30.49 |
| 2020-06-01 | 7:5 | No | $90.38 | $64.55 |
| 2019-06-25 | 7:5 | No | $33.26 | $23.76 |
About Zhejiang Starry Pharmaceutical Co.,Ltd.
Company overview and industry information
Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 7-for-5 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Zhejiang Starry Pharmaceutical Co.,Ltd. Summary